NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: Frost & Sullivan
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

mHealth for Diabetes and Heart Failure Will Revolutionize the Cardiometabolic Market Finds Frost & Sullivan - Novel cell and gene therapies, innovative drug delivery solutions and digital therapeutics for obesity, diabetes and CHF management to create growth opportunities, finds Frost & Sullivan
mHealth for Diabetes and Heart Failure Will Revolutionize the Cardiometabolic Market Finds Frost & Sullivan

 

NewswireToday - /newswire/ - Santa Clara, CA, United States, 2018/06/18 - Novel cell and gene therapies, innovative drug delivery solutions and digital therapeutics for obesity, diabetes and CHF management to create growth opportunities, finds Frost & Sullivan.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Across the global cardiometabolic diseases landscape, the chronic heart failure (CHF) and obesity segments show the strongest increase with a compound annual growth rate (CAGR) of 36.1 percent and 23.0 percent, respectively, during the forecast period of 2017 to 2022. Wellness programs are expected to be an integral part of cardiometabolic disease treatment, in collaboration with clinical therapies. New business models such as direct-to-consumer (DTC) and telemonitoring services are supporting market players in reaching larger patient bases, especially across remote areas with inadequate treatment access.

Frost & Sullivan, in partnership with CMHC, has recently released its analysis, Cardiometabolic Diseases Market Trends & Growth Opportunities, which highlights future trends, key regulatory and pricing changes, growth opportunities, and the impact of innovative therapeutic solutions on the overall market in the next few years.

Future growth opportunities in the cardiometabolic market include:

• Regenerative Medicine: Cell and gene therapies for heart failure and diabetes are set to transform the therapeutic landscape with novel treatment solutions;
• Innovative Drug Delivery Solutions: A transition toward nanoparticles-based inhalable and subcutaneous drug delivery systems is anticipated; and
• Digital Therapeutics: mHealth platforms for diabetes, obesity and heart failure management will revolutionize value-based care paradigms.

“The entire cardiometabolic treatment paradigm is slowly shifting toward a ‘Therapy-as-a-Service Model’ with the integration of drug treatment with well-defined nutritional, behavioral and wellness programs, thus providing the patients with a holistic treatment,” noted Aarti Chitale, Global Transformational Health Senior Research Analyst at Frost & Sullivan.

Needs are not being met across the market due to a general lack of novel therapies, leading to increased collaborative drug development and commercialization activities. Leading players resort to mergers and acquisitions (M&As) with smaller niche players, thereby attaining therapeutic expertise as well as geographic expansion. Pfizer’s recent collaboration with Wave Life Sciences is aimed at developing genetically-targeted therapies from Wave’s RNA interference (RNAi) capabilities for metabolic diseases.

Additionally, other key market participants such as Novartis are investing in evidence-based/outcomes-based cost-benefit studies for high-value drugs such as Entresto™ to establish the cost-effectiveness of these therapies. The adoption of value-based payment (VBP) models closely aligns reimbursements to quality and overall outcomes of a treatment, thus reducing the economic burden on the patients, providers, and payers.

“While the cost of treatment has been an impeding issue across the market, industry players are increasingly adopting a value-based payment model by linking it to the therapeutic outcome of the drug, thereby addressing the challenges of higher drug costs and supporting a larger patient base,” observed Chitale.

Cardiometabolic Diseases Market Trends & Growth Opportunities is part of Frost & Sullivan’s Transformational Health Life Sciences Growth Partnership Service program.

About Frost & Sullivan

Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

Cardiometabolic Diseases Market Trends & Growth Opportunities / MDB6_52

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


mHealth for Diabetes and Heart Failure Will Revolutionize the Cardiometabolic Market Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Mariana Fernandez - Frost.com 
210-348-1012 mariana.fernandez[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Health / Surgery Most Recent Related Newswires:

Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery
Lumeon Commended by Frost & Sullivan for Enabling Digital Transformation in Healthcare
Payment Integrity Solutions Enable Healthcare Plans to Optimize Processes and Maximize Returns Finds Frost & Sullivan
Menopause to Become the Next Game-changer in the Global Femtech Solutions Industry by 2025 Finds Frost & Sullivan
Innovative MedTech Business Models Will Enable Cost-effective, Decentralized and Patient-centric Care Finds Frost & Sullivan
Data Monetization a Must for MedTech Industry to Evolve Toward Real-World Evidence and Precision Medicine Finds Frost & Sullivan
InterSystems Partners with Cognetivity on Ground-breaking AI Solution for Early Dementia Detection
Humimic Medical, Partners Team Up to Make A Difference in South Carolina COVID Battle
Adoption of HaH Model Surged Eight-fold with the Availability of Advanced Remote Monitoring and Digital Health Solutions Finds Frost & Sullivan
Major Innovation Announcement Planned, SC Life Sciences Conference Shatters Registration Record
South Carolina Life Sciences Conference Adds Top Executives from Microsoft, Alphabet, PhRMA
SC Life Sciences Conference to Feature BIO Global Executive February 16-17
20Lighter Announces Orthopedic Surgery Alliance
Calmerry Introduces Individual, Couples and Family Online Therapy with Licensed Professionals
CoverMyMeds Lauded by Frost & Sullivan for Seamlessly Connecting the Healthcare Network with its Industry-leading ePA Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)